Literature DB >> 1725958

Ribosomal inhibitory proteins from plants inhibit HIV-1 replication in acutely infected peripheral blood mononuclear cells.

M C Olson1, S Ramakrishnan, R Anand.   

Abstract

Peripheral blood mononuclear cells from seronegative donors were stimulated with phytohemagglutinin and then infected with human immunodeficiency virus (HIV-1). Using this experimental system, the antiviral activity of two translation inhibitory proteins (pokeweed antiviral protein, PAP-S, and Luffa ribosomal inhibitory protein, LRIP-I) isolated from plants and a recombinant form of ricin A chain were studied. Previously, it had been shown that toxin polypeptides linked to monoclonal antibodies could inhibit HIV-infected cells. In the present study, the free, unconjugated, proteins were found to inhibit HIV replication at doses in which they were nontoxic to uninfected peripheral blood mononuclear cells. Among the inhibitory proteins, PAP-S and recombinant ricin A chain markedly reduced the reverse transcriptase activity and the expression of p24 core protein in infected cultures. Dose response studies indicate that the anti-HIV activity of PAP-S was comparable to AZT. The other ribosome inhibitory proteins (RIPs) showed moderate but significant antiviral activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725958     DOI: 10.1089/aid.1991.7.1025

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  7 in total

1.  Intestinal Shiga toxin-producing Escherichia coli bacteria mitigate bovine leukemia virus infection in experimentally infected sheep.

Authors:  Witold A Ferens; Rowland Cobbold; Carolyn J Hovde
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  An additional mechanism of ribosome-inactivating protein cytotoxicity: degradation of extrachromosomal DNA.

Authors:  E Nicolas; I D Goodyer; T F Taraschi
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

3.  Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex.

Authors:  J O Kahn; K J Gorelick; G Gatti; C J Arri; J D Lifson; J G Gambertoglio; A Bostrom; R Williams
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

4.  Antiviral activity of shiga toxin 1: suppression of bovine leukemia virus-related spontaneous lymphocyte proliferation.

Authors:  W A Ferens; C J Hovde
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  Antiviral activity of shiga toxin requires enzymatic activity and is associated with increased permeability of the target cells.

Authors:  Indira Basu; Witold A Ferens; Diana M Stone; Carolyn J Hovde
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

6.  Low numbers of intestinal Shiga toxin-producing E. coli correlate with a poor prognosis in sheep infected with bovine leukemia virus.

Authors:  Witold A Ferens; Julius Haruna; Rowland Cobbold; Carolyn J Hovde
Journal:  J Vet Sci       Date:  2008-12       Impact factor: 1.672

7.  Novel Binding Mechanisms of Fusion Broad Range Anti-Infective Protein Ricin A Chain Mutant-Pokeweed Antiviral Protein 1 (RTAM-PAP1) against SARS-CoV-2 Key Proteins in Silico.

Authors:  Yasser Hassan; Sherry Ogg; Hui Ge
Journal:  Toxins (Basel)       Date:  2020-09-17       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.